Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A (2011) 10.56

MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat Rev Clin Oncol (2011) 5.46

Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) (2011) 4.64

Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res (2011) 4.55

Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J (2010) 4.47

MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A (2011) 4.11

Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J Natl Cancer Inst (2013) 4.03

Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer (2010) 3.59

Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis (2009) 3.40

Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer (2010) 2.95

Haemolysis during sample preparation alters microRNA content of plasma. PLoS One (2011) 2.92

Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One (2011) 2.57

Extracellular microRNA: a new source of biomarkers. Mutat Res (2011) 2.55

MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer (2009) 2.45

The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ (2013) 2.41

Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels. Cancer Res (2010) 2.39

Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors. Genes Chromosomes Cancer (2010) 2.11

Modulation of mismatch repair and genomic stability by miR-155. Proc Natl Acad Sci U S A (2010) 2.05

Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Dig Dis Sci (2011) 2.02

MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proc Natl Acad Sci U S A (2010) 1.99

Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer (2011) 1.97

Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. Oncologist (2010) 1.91

Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clin Sci (Lond) (2011) 1.91

Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One (2014) 1.83

MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels. PLoS One (2011) 1.79

Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One (2011) 1.78

Fecal MicroRNAs as novel biomarkers for colon cancer screening. Cancer Epidemiol Biomarkers Prev (2010) 1.74

Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS One (2012) 1.66

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J Transl Med (2012) 1.62

Epigenetics of colorectal cancer. Gastroenterology (2012) 1.60

Circulating microRNAs as specific biomarkers for breast cancer detection. PLoS One (2013) 1.57

DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. Gastric Cancer (2014) 1.56

The Impact of Hemolysis on Cell-Free microRNA Biomarkers. Front Genet (2013) 1.54

Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer. Br J Cancer (2011) 1.53

Differential expression of circulating microRNAs according to severity of colorectal neoplasia. Transl Res (2015) 1.50

Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study. BMJ Open (2012) 1.50

Circulating microRNAs in cancer: origin, function and application. J Exp Clin Cancer Res (2012) 1.50

Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer (2013) 1.48

Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer. Ann Surg (2014) 1.46

MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression. Oncotarget (2014) 1.44

MicroRNAs: master regulators of ethanol abuse and toxicity? Alcohol Clin Exp Res (2010) 1.44

The role of microRNAs in colorectal cancer. Cancer J (2012) 1.44

MicroRNA signature analysis in colorectal cancer: identification of expression profiles in stage II tumors associated with aggressive disease. Int J Colorectal Dis (2011) 1.43

Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer. Br J Cancer (2013) 1.39

Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs. BMC Genomics (2011) 1.39

Identification and evaluation of plasma microRNAs for early detection of colorectal cancer. PLoS One (2013) 1.39

MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer. Neoplasia (2012) 1.39

Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. Chin J Cancer (2011) 1.38

Cell-free Circulating miRNA Biomarkers in Cancer. J Cancer (2012) 1.37

Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. PLoS One (2012) 1.36

Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis. Dig Dis Sci (2010) 1.35

Identifying microRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis. BMC Syst Biol (2012) 1.35

MicroRNA control of epithelial-mesenchymal transition and metastasis. Cancer Metastasis Rev (2012) 1.34

Identification and functional screening of microRNAs highly deregulated in colorectal cancer. J Cell Mol Med (2012) 1.34

Serum microRNA-155 as a potential biomarker to track disease in breast cancer. PLoS One (2012) 1.33

Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer. BMC Cancer (2012) 1.30

Circulating microRNA is a biomarker of pediatric Crohn disease. J Pediatr Gastroenterol Nutr (2011) 1.29

Non-coding RNAs: a key to future personalized molecular therapy? Genome Med (2010) 1.29

MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease. Immune Netw (2011) 1.29

Discovery of microRNAs and other small RNAs in solid tumors. Nucleic Acids Res (2010) 1.28

Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C. Proc Natl Acad Sci U S A (2013) 1.28

Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer. BMC Cancer (2013) 1.28

Colorectal cancer: from prevention to personalized medicine. World J Gastroenterol (2014) 1.26

Complex patterns of altered MicroRNA expression during the adenoma-adenocarcinoma sequence for microsatellite-stable colorectal cancer. Clin Cancer Res (2011) 1.25

MiRNA in innate immune responses: novel players in wound inflammation. Physiol Genomics (2010) 1.25

MicroRNAs: tools for cancer diagnostics. Gut (2009) 1.25

MicroRNAs as biomarkers in colorectal cancer. Am J Pathol (2010) 1.25

Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. Gastroenterology (2015) 1.24

Expression, circulation, and excretion profile of microRNA-21, -155, and -18a following acute kidney injury. Toxicol Sci (2012) 1.24

Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. Chin J Cancer Res (2013) 1.23

Selective upregulation of microRNA expression in peripheral blood leukocytes in IL-10-/- mice precedes expression in the colon. J Immunol (2011) 1.23

Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies. BMC Cancer (2011) 1.20

Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer. PLoS One (2013) 1.20

MicroRNA dysregulation in colorectal cancer: a clinical perspective. Br J Cancer (2011) 1.20

Circulating microRNAs as noninvasive biomarkers in breast cancer. Recent Results Cancer Res (2012) 1.19

Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer. Br J Cancer (2014) 1.19

Alterations of microRNAs contribute to colon carcinogenesis. Semin Oncol (2011) 1.19

Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus. PLoS One (2011) 1.18

Differential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence. BMC Cancer (2013) 1.18

Next-generation sequencing of microRNAs for breast cancer detection. J Biomed Biotechnol (2011) 1.17

U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis. Exp Mol Med (2013) 1.17

miR-190-mediated downregulation of PHLPP contributes to arsenic-induced Akt activation and carcinogenesis. Toxicol Sci (2011) 1.16

A combination of Let-7d, Let-7g and Let-7i serves as a stable reference for normalization of serum microRNAs. PLoS One (2013) 1.16

MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers. Cell Cycle (2013) 1.16

Differential expression of microRNAs in tumors from chronically inflamed or genetic (APC(Min/+)) models of colon cancer. PLoS One (2011) 1.16

Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer. J Gastroenterol (2011) 1.16

miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy. Int J Colorectal Dis (2012) 1.16

TGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness. Mol Cancer (2014) 1.15

A microRNA contribution to aberrant Ras activation in gastric cancer. Am J Transl Res (2011) 1.14

Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma. Br J Cancer (2014) 1.13

Altered serum microRNAs as biomarkers for the early diagnosis of pulmonary tuberculosis infection. BMC Infect Dis (2012) 1.13

Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer. Br J Cancer (2013) 1.12

Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer. PLoS One (2011) 1.12

Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy. Acta Pharmacol Sin (2012) 1.12

DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer. Biochem Biophys Res Commun (2014) 1.12

The prognostic value of microRNAs varies with patient race/ethnicity and stage of colorectal cancer. Clin Cancer Res (2013) 1.12

MicroRNAs as potential biomarkers in cancer: opportunities and challenges. Biomed Res Int (2015) 1.12

Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. J Transl Med (2013) 1.11

MicroRNA-21 as a potential colon and rectal cancer biomarker. World J Gastroenterol (2013) 1.10

Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease. Blood (2013) 1.10

Initial sequencing and analysis of the human genome. Nature (2001) 212.86

A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A (1998) 24.58

Integrating functional genomic information into the Saccharomyces genome database. Nucleic Acids Res (2000) 18.52

A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci U S A (1990) 14.22

Mutations of mitotic checkpoint genes in human cancers. Nature (1998) 11.20

The RNA component of human telomerase. Science (1995) 9.86

Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature (1996) 7.90

The Stanford Microarray Database. Nucleic Acids Res (2001) 7.77

Genome-wide expression profiling in Escherichia coli K-12. Nucleic Acids Res (1999) 7.20

Analysis of human transcriptomes. Nat Genet (1999) 6.14

Selective solubilization of proteins from red blood cell membranes by protein perturbants. J Supramol Struct (1973) 5.18

Role of BAX in the apoptotic response to anticancer agents. Science (2000) 5.07

A second chromosomal gene necessary for intimate attachment of enteropathogenic Escherichia coli to epithelial cells. J Bacteriol (1993) 5.02

Selective solubilization of proteins and phospholipids from red blood cell membranes by nonionic detergents. J Supramol Struct (1973) 4.95

Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy. Nat Med (1998) 4.16

Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene (2008) 3.92

Towards functional characterisation of the members of the R2R3-MYB gene family from Arabidopsis thaliana. Plant J (1998) 3.75

The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol (1990) 3.57

Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron (1995) 3.37

Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers. Aliment Pharmacol Ther (2012) 3.35

Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell (1995) 3.34

Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon. Infect Immun (2001) 3.28

Capsule endoscopy in acute upper gastrointestinal hemorrhage: a prospective cohort study. Endoscopy (2012) 3.28

Cell-cycle arrest versus cell death in cancer therapy. Nat Med (1997) 3.18

Treatment of severe acute respiratory syndrome with convalescent plasma. Hong Kong Med J (2003) 3.01

c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nat Genet (1999) 2.95

Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation (1998) 2.90

Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83

Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells. Mol Pharmacol (1998) 2.81

Dyspepsia is strongly associated with major depression and generalised anxiety disorder - a community study. Aliment Pharmacol Ther (2012) 2.80

Double echo steady state magnetic resonance imaging of knee articular cartilage at 3 Tesla: a pilot study for the Osteoarthritis Initiative. Ann Rheum Dis (2005) 2.76

Saccharomyces Genome Database provides tools to survey gene expression and functional analysis data. Nucleic Acids Res (2001) 2.71

Beclin 1 contains a leucine-rich nuclear export signal that is required for its autophagy and tumor suppressor function. Cancer Res (2001) 2.51

Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat Med (2001) 2.47

Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat Med (2000) 2.44

Modification of lignin biosynthesis in transgenic Nicotiana through expression of an antisense O-methyltransferase gene from Populus. Plant Mol Biol (1994) 2.42

Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci U S A (2001) 2.40

Multiple-complete-digest restriction fragment mapping: generating sequence-ready maps for large-scale DNA sequencing. Proc Natl Acad Sci U S A (1997) 2.36

Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: A randomized trial. JAMA (2000) 2.29

Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner. J Virol (2004) 2.26

Function search in a large transcription factor gene family in Arabidopsis: assessing the potential of reverse genetics to identify insertional mutations in R2R3 MYB genes. Plant Cell (1999) 2.23

MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene (2010) 2.23

Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol (2004) 2.21

Regulation of pim and myb mRNA accumulation by interleukin 2 and interleukin 3 in murine hematopoietic cell lines. J Biol Chem (1988) 2.19

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials. Aliment Pharmacol Ther (2014) 2.17

Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches. Cancer Metastasis Rev (2001) 2.16

Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies. J Neurochem (2001) 2.14

Transcription of a recombinant bunyavirus RNA template by transiently expressed bunyavirus proteins. Virology (1995) 2.13

Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins. J Biol Chem (1994) 2.07

White-light filaments for atmospheric analysis. Science (2003) 2.07

Reconstitution of intramembrane particles in recombinants of erythrocyte protein band 3 and lipid: effects of spectrin-actin association. Proc Natl Acad Sci U S A (1976) 2.07

Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species. Cancer Res (2001) 2.05

High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin Infect Dis (2013) 2.02

mRNA stabilization by the ompA 5' untranslated region: two protective elements hinder distinct pathways for mRNA degradation. RNA (1998) 1.89

Leisure-time physical activity, television watching, and plasma biomarkers of obesity and cardiovascular disease risk. Am J Epidemiol (2000) 1.89

MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer (2009) 1.88

Large scale purification and immunolocalization of bovine uroplakins I, II, and III. Molecular markers of urothelial differentiation. J Biol Chem (1990) 1.88

A precision measurement of the mass of the top quark. Nature (2004) 1.87

Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database. J Urol (2000) 1.85

High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas. Oncogene (2008) 1.84

Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis. Oncogene (2006) 1.82

Pathogenesis of the Segond fracture: anatomic and MR imaging evidence of an iliotibial tract or anterior oblique band avulsion. Radiology (2001) 1.82

PUMA is directly activated by NF-kappaB and contributes to TNF-alpha-induced apoptosis. Cell Death Differ (2009) 1.81

Outcomes of adults hospitalised with severe influenza. Thorax (2010) 1.80

Apoptosis: an early event in metastatic inefficiency. Cancer Res (2001) 1.74

Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer. Ann Surg Oncol (2007) 1.73

Assembly of high-resolution restriction maps based on multiple complete digests of a redundant set of overlapping clones. Genomics (1996) 1.72

Human papillomavirus (HPV) infection in seborrheic keratosis. Am J Dermatopathol (1989) 1.71

Two year longitudinal change and test-retest-precision of knee cartilage morphology in a pilot study for the osteoarthritis initiative. Osteoarthritis Cartilage (2007) 1.71

Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut (2004) 1.68

Increased expression of Aspergillus parasiticus aflR, encoding a sequence-specific DNA-binding protein, relieves nitrate inhibition of aflatoxin biosynthesis. Appl Environ Microbiol (1995) 1.66

Codon bias at the 3'-side of the initiation codon is correlated with translation initiation efficiency in Escherichia coli. Gene (2001) 1.65

New genotype of avian influenza H5N1 viruses isolated from tree sparrows in China. J Virol (2005) 1.64

Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. J Cardiovasc Pharmacol (1996) 1.63

A matter of time: evaluating the storage of fecal samples for steroid analysis. Gen Comp Endocrinol (2002) 1.62

The autophagic paradox in cancer therapy. Oncogene (2011) 1.61

Syndeins: the spectrin-binding protein(s) of the human erythrocyte membrane. Proc Natl Acad Sci U S A (1979) 1.60

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis. Oncogene (2009) 1.58

The TGF-beta signaling pathway is essential for Drosophila oogenesis. Development (1996) 1.58

Treatment with growth hormone enhances contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure. Circulation (1999) 1.58

Drosha in primary microRNA processing. Cold Spring Harb Symp Quant Biol (2006) 1.58

Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection. Clin Infect Dis (2007) 1.57

ADR1-mediated regulation of ADH2 requires an inverted repeat sequence. Mol Cell Biol (1986) 1.57

CDX2 is mutated in a colorectal cancer with normal APC/beta-catenin signaling. Oncogene (1999) 1.57

Fatal and hospitalized injuries resulting from the 1994 Northridge earthquake. Int J Epidemiol (1998) 1.54

NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther (2003) 1.54

Measurement of the forward-backward charge asymmetry in top-quark pair production. Phys Rev Lett (2008) 1.53

Intrarectal administration of mCRAMP-encoding plasmid reverses exacerbated colitis in Cnlp(-/-) mice. Gene Ther (2012) 1.53

Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice. J Immunol (2000) 1.52